To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06537310
Title A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP | DNK | CAN | BEL | AUS

Facility Status City State Zip Country Details
Kinghorn Cancer Centre RECRUITING Darlinghurst New South Wales 2010 Australia Details
Austin Health RECRUITING Heidelberg Victoria 3084 Australia Details
UZ Leuven Gasthuisberg RECRUITING Leuven 3000 Belgium Details
BC Cancer ? Vancouver RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Princess Margaret Cancer Center RECRUITING Toronto Ontario M5G 2M9 Canada Details
McGill University Health Center RECRUITING Montreal Quebec H4A 3J1 Canada Details
Rigshospitalet RECRUITING København Ø 2100 Denmark Details
Clinica Universidad de Navarra RECRUITING Pamplona Navarra 31008 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona RECRUITING Barcelona 08035 Spain Details
Clinica Universidad de Navarra Madrid RECRUITING Madrid 28027 Spain Details
Fundacion Jimenez Diaz RECRUITING Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field